← Back to Search

Ultrasound for Skin Lesions

N/A

Waitlist Available

Led By Mohammad K. Khan, MD, PhD

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months from study start

Awards & highlights

Study Summary

This trial uses a new ultrasound technique to diagnose skin lesions. It may be a less invasive way to check for skin cancer and other disorders.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months from study start

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months from study start

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months from study start for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Pre and post treatment changes in lesions

Trial Design

3Treatment groups

Experimental Treatment

Group I: Cohort III (ultrasound)Experimental Treatment1 Intervention

Participants with inflammatory skin disorders (psoriasis, eczema, alopecia, acne) undergo ultrasound at baseline and follow-up visits.

Group II: Cohort II (ultrasound)Experimental Treatment1 Intervention

Skin cancer patients who undergo surgery or radiation undergo 2-5 ultrasounds over a 1 year period (a baseline ultrasound scan may be performed prior to treatment, followed by 1 scan during and/or after radiation, and additional ultrasounds may be conducted [at the discretion of the treating physician] upon completion of radiation and/or surgery, at approximately 1, 6, and 12 month follow-up examinations).

Group III: Cohort I (ultrasound)Experimental Treatment1 Intervention

Patients with skin lesions undergo at least 1 ultrasound during the consultation. Patients may undergo at most 2 additional scans after the standard of care approach for non-malignant lesions at the discretion of the radiation oncologist and/or dermatologist.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Ultrasound

2013

Completed Phase 1

~1950

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor

1,636 Previous Clinical Trials

2,560,526 Total Patients Enrolled

Mohammad K. Khan, MD, PhDPrincipal Investigator - Emory University

Emory University

3 Previous Clinical Trials

53 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is this clinical trial involving participants?

"Affirmative, the clinicaltrials.gov website attests that this particular research is currently recruiting candidates. The trial was first listed on April 29th 2019 and updated lastly on May 19th 2022 with an aim to enrol sixty patients from one site."

Answered by AI

Are there still openings for enrolment in this clinical trial?

"As evidenced on clinicaltrials.gov, this research is actively enrolling participants. The posting of the study dates back to April 29th 2019 and was last updated on May 19th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Ultrasound in Diagnosing Patients With Skin Lesions

Mohammad K. Khan 2019. "Ultrasound in Diagnosing Patients With Skin Lesions". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03914846.